PRESS RELEASE published on 09/24/2024 at 11:51, 4 hours 34 minutes ago Original-Research: Pentixapharm Holding AG (von BankM AG): n.a. Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF published on 09/23/2024 at 12:20, 1 day 4 hours ago Pentixapharm Holding AG Sets Price Range for Planned IPO Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
BRIEF published on 09/23/2024 at 12:20, 1 day 4 hours ago Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
PRESS RELEASE published on 09/23/2024 at 12:15, 1 day 4 hours ago Pentixapharm Holding AG Sets Price Range for Planned IPO Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF published on 09/12/2024 at 15:05, 12 days 1 hour ago Pentixapharm Holding AG Plans IPO on Frankfurt Stock Exchange Frankfurt Stock Exchange Cancer Treatment IPO Radiopharmaceuticals Phase III Trials
BRIEF published on 09/12/2024 at 15:05, 12 days 1 hour ago Pentixapharm Holding AG envisage une introduction en bourse à Francfort Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III
PRESS RELEASE published on 09/12/2024 at 15:00, 12 days 1 hour ago Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG, a subsidiary of Eckert & Ziegler SE, plans IPO on the Prime Standard of the Frankfurt Stock Exchange, focusing on innovative radiopharmaceuticals for theranostics of various indications Frankfurt Stock Exchange IPO Radiopharmaceuticals Pentixapharm Holding AG Theranostics
Published on 09/24/2024 at 16:15, 10 minutes ago Jericho Energy Ventures to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Published on 09/24/2024 at 16:00, 25 minutes ago High Rise Financial Obtains $100 Million in Financing, Bryant Park Capital Acting as Exclusive Advisor
Published on 09/24/2024 at 16:00, 25 minutes ago Letter to Shareholders From MobiCard CEO: Corporate Update
Published on 09/24/2024 at 16:00, 25 minutes ago BluSky Carbon Secures US$105 Million Biochar Sales Agreement
Published on 09/24/2024 at 16:00, 25 minutes ago Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch
Published on 09/24/2024 at 16:14, 11 minutes ago Edison issues report on International Public Partnerships (INPP)
Published on 09/24/2024 at 16:06, 19 minutes ago Original-Research: Grand City Properties SA (von First Berlin Equity Research GmbH): Kaufen
Published on 09/24/2024 at 15:50, 35 minutes ago The Platform Group AG: Acquisition of the 0815 Group in Austria
Published on 09/24/2024 at 15:24, 1 hour 1 minute ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 09/24/2024 at 15:22, 1 hour 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 09/24/2024 at 14:40, 1 hour 45 minutes ago Half-year financial report for the period ended 30 June 2024
Published on 09/24/2024 at 08:30, 7 hours 55 minutes ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 16/09/2024 tot 20/09/2024
Published on 09/24/2024 at 08:30, 7 hours 55 minutes ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 16/09/2024 au 20/09/2024
Published on 09/24/2024 at 08:30, 7 hours 55 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 16/09/2024 to 20/09/2024